Marwit Capital

What is Marwit Capital?

Marwit Capital, established in 1962, stands as one of the most seasoned private investment firms within the United States, focusing on mid-market companies. They zero in on businesses situated in the western U.S. with annual revenues typically in the spectrum of $20 million to $200 million, and EBITDA ranging from $4 million to $20 million.

Their preferred enterprise values are up to $100 million, but they remain open to considering more substantial transactions. Marwit Capital invests prevalently in software, IT and TMT, media, biotech, business solutions, hardware and manufacturing, energy, cleantech, healthtech and fitness, food and beverage, logistics and distribution, material science, and medical devices and hospital services.

The firm demonstrates a flexible investment approach, with potential investment sizes ranging from $5 million to $10 million.

They predominantly engage with companies involved in infrastructure, healthcare services, healthy living products and services, industrial products and services, business services, renewable resources, and retail and entertainment sectors.

Marwit prides itself on its significant portfolio, which includes ownership of 11 businesses, collectively generating about $600 million in revenue, and providing employment for 2,000 individuals spread across 17 states and 3 countries. With $200 million in equity capital presently under management for its limited partners, Marwit is actively investing through MCP II, which denotes Marwit's second institutional investment fund.